Literature DB >> 28041956

Basal Ganglia Dysfunction Contributes to Physical Inactivity in Obesity.

Danielle M Friend1, Kavya Devarakonda1, Timothy J O'Neal1, Miguel Skirzewski2, Ioannis Papazoglou1, Alanna R Kaplan3, Jeih-San Liow4, Juen Guo1, Sushil G Rane1, Marcelo Rubinstein5, Veronica A Alvarez3, Kevin D Hall1, Alexxai V Kravitz6.   

Abstract

Obesity is associated with physical inactivity, which exacerbates the health consequences of weight gain. However, the mechanisms that mediate this association are unknown. We hypothesized that deficits in dopamine signaling contribute to physical inactivity in obesity. To investigate this, we quantified multiple aspects of dopamine signaling in lean and obese mice. We found that D2-type receptor (D2R) binding in the striatum, but not D1-type receptor binding or dopamine levels, was reduced in obese mice. Genetically removing D2Rs from striatal medium spiny neurons was sufficient to reduce motor activity in lean mice, whereas restoring Gi signaling in these neurons increased activity in obese mice. Surprisingly, although mice with low D2Rs were less active, they were not more vulnerable to diet-induced weight gain than control mice. We conclude that deficits in striatal D2R signaling contribute to physical inactivity in obesity, but inactivity is more a consequence than a cause of obesity. Published by Elsevier Inc.

Entities:  

Keywords:  D2; dopamine; exercise; obese; obesity; physical activity; striatum; weight loss

Mesh:

Substances:

Year:  2016        PMID: 28041956      PMCID: PMC5299005          DOI: 10.1016/j.cmet.2016.12.001

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  70 in total

1.  Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry.

Authors:  Alexxai V Kravitz; Benjamin S Freeze; Philip R L Parker; Kenneth Kay; Myo T Thwin; Karl Deisseroth; Anatol C Kreitzer
Journal:  Nature       Date:  2010-07-07       Impact factor: 49.962

2.  A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation.

Authors:  I C Kilpatrick; M W Jones; O T Phillipson
Journal:  J Neurochem       Date:  1986-06       Impact factor: 5.372

Review 3.  Hormonal and neural mechanisms of food reward, eating behaviour and obesity.

Authors:  Susan Murray; Alastair Tulloch; Mark S Gold; Nicole M Avena
Journal:  Nat Rev Endocrinol       Date:  2014-06-24       Impact factor: 43.330

4.  Dopaminergic dysregulation in mice selectively bred for excessive exercise or obesity.

Authors:  Wendy Foulds Mathes; Derrick L Nehrenberg; Ryan Gordon; Kunjie Hua; Theodore Garland; Daniel Pomp
Journal:  Behav Brain Res       Date:  2010-02-13       Impact factor: 3.332

Review 5.  Reward mechanisms in obesity: new insights and future directions.

Authors:  Paul J Kenny
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

6.  Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling.

Authors:  Julia C Lemos; Danielle M Friend; Alanna R Kaplan; Jung Hoon Shin; Marcelo Rubinstein; Alexxai V Kravitz; Veronica A Alvarez
Journal:  Neuron       Date:  2016-05-18       Impact factor: 17.173

7.  Low Dopamine D2 Receptor Increases Vulnerability to Obesity Via Reduced Physical Activity, Not Increased Appetitive Motivation.

Authors:  Jeff A Beeler; Rudolf P Faust; Susie Turkson; Honggang Ye; Xiaoxi Zhuang
Journal:  Biol Psychiatry       Date:  2015-07-26       Impact factor: 13.382

8.  Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat.

Authors:  Jon F Davis; Andrea L Tracy; Jennifer D Schurdak; Matthias H Tschöp; Jack W Lipton; Deborah J Clegg; Stephen C Benoit
Journal:  Behav Neurosci       Date:  2008-12       Impact factor: 1.912

9.  Self-reported and objective physical activity in postgastric bypass surgery, obese and lean adults: association with body composition and cardiorespiratory fitness.

Authors:  Farah A Ramirez-Marrero; John Miles; Michael J Joyner; Timothy B Curry
Journal:  J Phys Act Health       Date:  2013-01-28

10.  Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies.

Authors:  A I Levey; S M Hersch; D B Rye; R K Sunahara; H B Niznik; C A Kitt; D L Price; R Maggio; M R Brann; B J Ciliax
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

View more
  40 in total

1.  Objectively measured sedentary time and physical activity and associations with body weight gain: does body weight determine a decline in moderate and vigorous intensity physical activity?

Authors:  U Ekelund; E Kolle; J Steene-Johannessen; K E Dalene; A K O Nilsen; S A Anderssen; B H Hansen
Journal:  Int J Obes (Lond)       Date:  2017-08-04       Impact factor: 5.095

Review 2.  Disentangling the diverse roles of dopamine D2 receptors in striatal function and behavior.

Authors:  Eduardo F Gallo
Journal:  Neurochem Int       Date:  2019-02-01       Impact factor: 3.921

3.  Striatal Dopamine D2 Receptors Regulate Cost Sensitivity and Behavioral Thrift.

Authors:  Devry Mourra; Federico Gnazzo; Steve Cobos; Jeff A Beeler
Journal:  Neuroscience       Date:  2019-12-03       Impact factor: 3.590

4.  Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis.

Authors:  Mikolaj Ogrodnik; Yi Zhu; Larissa G P Langhi; Tamar Tchkonia; Patrick Krüger; Edward Fielder; Stella Victorelli; Rifqha A Ruswhandi; Nino Giorgadze; Tamar Pirtskhalava; Oleg Podgorni; Grigori Enikolopov; Kurt O Johnson; Ming Xu; Christine Inman; Allyson K Palmer; Marissa Schafer; Moritz Weigl; Yuji Ikeno; Terry C Burns; João F Passos; Thomas von Zglinicki; James L Kirkland; Diana Jurk
Journal:  Cell Metab       Date:  2019-01-03       Impact factor: 27.287

5.  Dopamine D2 Receptor Signaling in the Nucleus Accumbens Comprises a Metabolic-Cognitive Brain Interface Regulating Metabolic Components of Glucose Reinforcement.

Authors:  Michael Michaelides; Michael L Miller; Jennifer A DiNieri; Juan L Gomez; Elizabeth Schwartz; Gabor Egervari; Gene Jack Wang; Charles V Mobbs; Nora D Volkow; Yasmin L Hurd
Journal:  Neuropsychopharmacology       Date:  2017-06-05       Impact factor: 7.853

6.  The α2δ-1-NMDA receptor coupling is essential for corticostriatal long-term potentiation and is involved in learning and memory.

Authors:  Jing-Jing Zhou; De-Pei Li; Shao-Rui Chen; Yi Luo; Hui-Lin Pan
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157

7.  Metaplasticity in the Ventral Pallidum as a Potential Marker for the Propensity to Gain Weight in Chronic High-Calorie Diet.

Authors:  Shani Gendelis; Dorrit Inbar; Kineret Inbar; Shanee Mesner; Yonatan M Kupchik
Journal:  J Neurosci       Date:  2020-11-16       Impact factor: 6.167

8.  Striatal dopamine 2 receptor upregulation during development predisposes to diet-induced obesity by reducing energy output in mice.

Authors:  Marie A Labouesse; Andrea M Sartori; Oliver Weinmann; Eleanor H Simpson; Christoph Kellendonk; Ulrike Weber-Stadlbauer
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-25       Impact factor: 11.205

Review 9.  Persistent effects of obesity: a neuroplasticity hypothesis.

Authors:  Bridget A Matikainen-Ankney; Alexxai V Kravitz
Journal:  Ann N Y Acad Sci       Date:  2018-05-09       Impact factor: 5.691

10.  Hypothalamic dopamine signaling regulates brown fat thermogenesis.

Authors:  Cintia Folgueira; Daniel Beiroa; Begoña Porteiro; Manon Duquenne; Emma Puighermanal; Marcos F Fondevila; Silvia Barja-Fernández; Rosalia Gallego; René Hernández-Bautista; Cecilia Castelao; Ana Senra; Patricia Seoane; Noemi Gómez; Pablo Aguiar; Diana Guallar; Miguel Fidalgo; Amparo Romero-Pico; Roger Adan; Clemence Blouet; Jose Luís Labandeira-García; Françoise Jeanrenaud; Imre Kallo; Zsolt Liposits; Javier Salvador; Vincent Prevot; Carlos Dieguez; Miguel Lopez; Emmanuel Valjent; Gema Frühbeck; Luisa M Seoane; Ruben Nogueiras
Journal:  Nat Metab       Date:  2019-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.